Financhill
Back

INmune Bio 10K Form

Sell
41

INMB
INmune Bio

Last Price:
5.84
Seasonality Move:
36.39%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive INMB News And Ratings

See the #1 stock for the next 7 days that we like better than INMB

INMB Financial Statistics

Sales & Book Value

Annual Sales: $155K
Cash Flow: $-7.89M
Price / Cash Flow: 0
Annual Sales: $1.87
Price / Book: 3.36

Profitability

EPS (TTM): -2.06000
Net Income (TTM): $-37.74M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

INmune Bio Earnings Forecast

Key INmune Bio Financial Ratios

  • The Research & Development expenses have been 13,079.35% of Revenue.
  • The Net Earning history of INMB is -19,360.00% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 2 years.

INmune Bio Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: INMB
CUSIP: 45782T
Website: inmunebio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

INMB Technical Analysis vs Fundamental Analysis

Sell
41
INmune Bio (INMB) is a Sell

Is INmune Bio a Buy or a Sell?

  • INmune Bio stock is rated a Sell
    The current INmune Bio [INMB] share price is $5.95. The Score for INMB is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.